Congratulations to Dr. Sofia Meyer zu Reckendorf on receiving the Oppenheim Award!
She was honored by Novartis Pharma GmbH for her outstanding research in the field of "Multiple Sclerosis – Research and Understanding" in the Preclinical category. The award, valued at €50,000, recognizes both her scientific achievements and her innovative project titled "Involvement of CASPR in axonal loss in multiple sclerosis patients."
The official announcement of the 2024 award winners took place during the Novartis Satellite Symposium at this year's conference of the German Society of Neurology (DGN).
This prestigious award highlights an important contribution to Multiple Sclerosis research, offering new insights into the mechanisms of the disease and fostering hope for future therapies.
See press releases at:
www.aerzteblatt.de/foerderpreise/verleihung
www.novartis.com/de-de/medien/pressemitteilungen/innovative-multiple-sklerose-forschung-im-fokus-novartis-verleiht-15-oppenheim-foerderpreis